NDC 0078-1483 – Rhapsido
Remibrutinib 25 mg/1 · Tablet · Oral
Product NDC0078-1483
Product details
- Brand name
- Rhapsido
- Generic name
- Remibrutinib
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA218436
- Marketed since
- September 30, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Remibrutinib 25 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0078-1483-20 | 60 TABLET in 1 BOTTLE (0078-1483-20) | Sep 30, 2025 |
| 0078-1483-92 sample | 2 BOTTLE in 1 CARTON (0078-1483-92) / 30 TABLET in 1 BOTTLE | Sep 30, 2025 |
| 0078-1483-93 sample | 30 TABLET in 1 BOTTLE (0078-1483-93) | Mar 23, 2026 |